A Study of FZ-AD005 in Patients With Advanced Solid Tumors
RecruitingNCT06424665
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)
Start: 2024-07-03End: 2027-12-01Target: 162Updated: 2026-03-04
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
Not yet recruitingNCT07455045
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.Diffuse Midline Glioma (DMG), Glioblastoma (GBM), High Grade Glioma (III or IV)
Start: 2026-03-01End: 2028-06-01Target: 40Updated: 2026-03-06